Literature DB >> 12136361

Carotid artery stenosis: contrast-enhanced MR angiography with two different scan times compared with digital subtraction angiography.

P C Sundgren1, P Sundén, A Lindgren, J Lanke, S Holtås, E-M Larsson.   

Abstract

Contrast enhanced magnetic resonance angiography (CE MRA) is a non-invasive alternative to conventional digital subtraction angiography (DSA). CE MRA is increasingly used as a complement to Duplex in the preoperative assessment of carotid artery stenosis. The purpose of this study was to determine if CE MRA could replace preoperative DSA. CE MRA with a scan time of 10 or 28 s was performed in 24 consecutive patients who were scheduled for preoperative DSA because of Duplex-verified severe carotid artery stenosis. Two neuroradiologists measured the degree of stenosis with three different methods, and the image quality was evaluated. DSA was used as the gold standard. For detection of severe stenosis (N. American symptomatic carotid endarterectomy trial (NASCET) > or =70%; European symptomatic carotid endarterectomy trial (ECST) > or =80%; common carotid artery method (CCAM) > or =80%), the sensitivity of CE MRA maximum intensity projection (MIP) compared with DSA was 82%-100 %, the specificity was 74%-93% and the accuracy was 77%-90%. The inter-observer agreement was higher, the image quality was better and the intracranial main arteries were better visualized with the 28 s than with the 10 s scan time. The enhancement of the jugular veins seen in 17% of the 10 s scans and in 58% of the patients with the 28 s scans did not interfere with the evaluation of the carotid arteries. CE MRA, preferably with a scan time of 28 s, can replace DSA in the preoperative assessment of most patients with carotid artery stenosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12136361     DOI: 10.1007/s00234-002-0789-8

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  7 in total

1.  Dose optimization of contrast-enhanced carotid MR angiography.

Authors:  M Unterweger; J M Froehlich; R A Kubik-Huch; B Seifert; M Birrer; T Huber; R Otto
Journal:  Eur Radiol       Date:  2005-05-05       Impact factor: 5.315

2.  Contrast-enhanced MR angiography of the carotid and vertebrobasilar circulations.

Authors:  Carina W Yang; James C Carr; Stephen F Futterer; Mark D Morasch; Benson P Yang; Stephanie M Shors; J Paul Finn
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  MR angiography at 3 Tesla to assess proximal internal carotid artery stenoses: contrast-enhanced or 3D time-of-flight MR angiography?

Authors:  J Weber; P Veith; B Jung; G Ihorst; O Moske-Eick; S Meckel; H Urbach; C A Taschner
Journal:  Clin Neuroradiol       Date:  2014-01-03       Impact factor: 3.649

4.  Magnetic resonance angiography of the carotid arteries: comparison of unenhanced and contrast enhanced techniques.

Authors:  Harald Kramer; Val M Runge; John N Morelli; Kenneth D Williams; L Gill Naul; Konstantin Nikolaou; Maximilian F Reiser; Bernd J Wintersperger
Journal:  Eur Radiol       Date:  2011-04-09       Impact factor: 5.315

5.  Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.

Authors:  Jens Harald Kramer; Elisabeth Arnoldi; Christopher J François; Andrew L Wentland; Konstantin Nikolaou; Bernd J Wintersperger; Thomas M Grist
Journal:  Invest Radiol       Date:  2013-03       Impact factor: 6.016

6.  Carotid artery stenosis: reproducibility of automated 3D CT angiography analysis method.

Authors:  Zishu Zhang; Marja H Berg; Aki E J Ikonen; Ritva L Vanninen; Hannu I Manninen
Journal:  Eur Radiol       Date:  2003-11-14       Impact factor: 5.315

7.  Accuracy of 3 T MR angioraphy in vertebral artery stenosis and coincidence with other cerebrovascular stenoses.

Authors:  Hyun Seok Choi; Dong Ik Kim; Dong Joon Kim; Jinna Kim; Eun Soo Kim; Seung-Koo Lee
Journal:  Neuroradiology       Date:  2010-01-28       Impact factor: 2.804

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.